After 48 h of treatment, the results of the trypan blue exclusion experiment indicated that low concentrations of ferric citrate promoted the proliferation of wild-type TP53 AML cells, whereas high concentrations inhibited it (Figure 3A). Here, TP53 is linked to acute myeloid leukemia.